Jin Medical International (ZJYL) Enterprise Value (2022 - 2025)

Jin Medical International (ZJYL) has reported Enterprise Value for 4 consecutive years, with -$29.7 million the latest figure, recorded in Q3 2025.

• Quarterly Enterprise Value fell 9.9% year-over-year to -$29.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$29.7 million (down 9.9% YoY) and the FY2025 annual result came in at -$29.7 million, down 9.9% from the prior year.
• Enterprise Value advanced to -$29.7 million in Q3 2025 per ZJYL's latest filing, from -$31.1 million in the prior quarter.
• Over the last five years, Enterprise Value for ZJYL reached as high as -$7.1 million in Q3 2022 and fell as low as -$31.1 million in Q1 2025.
• A 4-year average of -$21.6 million and a median of -$26.1 million in 2024 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2023 — Enterprise Value tumbled 136.23% — and 2025, when it declined 9.9%.
• Year by year, Enterprise Value stood at -$7.1 million in 2022, then slumped by 136.23% to -$16.7 million in 2023, then plunged by 61.81% to -$27.0 million in 2024, then declined by 9.9% to -$29.7 million in 2025.
• According to Business Quant data, Enterprise Value over the past three periods registered -$29.7 million, -$31.1 million, and -$27.0 million for Q3 2025, Q1 2025, and Q3 2024 respectively.